[{"id":"8543842","sourceId":"globe-newswire","sourceName":"GlobeNewswire","providerName":"GlobeNewswire","title":"Celularity Reports First Quarter 2022 Financial Results and Provides Corporate Update","publishedDate":"2022-05-16T15:10:00-05:00"},{"id":"20220513cg56996","sourceId":"pr-newswire","sourceName":"PR Newswire","providerName":"PR Newswire","title":"Thinking about buying stock in Affirm Holdings, Celularity, Robinhood Markets, Endeavor Group, or Toast?","publishedDate":"2022-05-13T07:30:00-05:00"},{"id":"8514201","sourceId":"globe-newswire","sourceName":"GlobeNewswire","providerName":"GlobeNewswire","title":"Celularity Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update","publishedDate":"2022-03-31T15:05:00-05:00"},{"id":"8503703","sourceId":"globe-newswire","sourceName":"GlobeNewswire","providerName":"GlobeNewswire","title":"Celularity to Present at Oppenheimer 32nd Annual Healthcare Conference","publishedDate":"2022-03-15T15:05:00-05:00"},{"id":"202112272700","sourceId":"dow-jones","sourceName":"Global News Select","providerName":"Dow Jones","title":"Celularity Gets FDA Fast-Track Designation for Cancer Treatment","publishedDate":"2021-12-27T07:33:00-06:00"},{"id":"202111295809","sourceId":"dow-jones","sourceName":"Global News Select","providerName":"Dow Jones","title":"Celularity Gets FDA Clearance of IND Application for CYNK-101 in Gastric Cancer","publishedDate":"2021-11-29T07:43:00-06:00"}]